13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Translational Neurology
Translational neurology bridges the gap between laboratory research and clinical application, accelerating advancements in neurological care. By transforming fundamental discoveries into practical treatments, this field addresses unmet medical needs in conditions such as Parkinson’s disease, Alzheimer’s, and spinal cord injuries. Translational Neurology emphasizes the importance of preclinical studies in developing targeted therapies, ensuring their efficacy and safety before clinical trials. Emerging technologies like gene editing and stem cell therapy are pivotal in shaping innovative approaches for neurological repair and regeneration. Collaborative efforts between researchers and clinicians foster real-world applications, ultimately enhancing patient outcomes and paving the way for groundbreaking interventions.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States